← Back to valorpeptides.com

Lab tests for valorpeptides.com

73 independent lab tests · 99.4% average HPLC purity

MAY 16, 2026
Tesamorelin
tested by Accumark Labs
99.58%
View COA →
MAY 15, 2026
Tirzepatide
tested by Accumark Labs
99.66%
View COA →
MAY 14, 2026
GHK-Cu
tested by Accumark Labs
98.94%
View COA →
MAY 14, 2026
SEMAX
tested by Accumark Labs
99.50%
View COA →
MAY 12, 2026
NAD+
tested by Accumark Labs
99.70%
View COA →
MAY 8, 2026
TB-500
tested by Accumark Labs
99.31%
View COA →
MAY 6, 2026
SELANK
tested by Accumark Labs
99.63%
View COA →
MAY 4, 2026
BPC-157
tested by Accumark Labs
98.63%
View COA →
APR 30, 2026
Tirzepatide
tested by Accumark Labs
99.68%
View COA →
APR 30, 2026
BPC-157
tested by Accumark Labs
99.25%
View COA →
APR 29, 2026
MOTS-C
tested by Accumark Labs
99.43%
View COA →
APR 25, 2026
Sermorelin
tested by Accumark Labs
98.90%
View COA →
APR 23, 2026
Tesamorelin
tested by Accumark Labs
99.32%
View COA →
APR 22, 2026
BPC-157
tested by Accumark Labs
98.29%
View COA →
APR 21, 2026
Retatrutide
tested by Accumark Labs
99.92%
View COA →
APR 21, 2026
Tirzepatide
tested by Accumark Labs
99.42%
View COA →
APR 16, 2026
CJC-1295 without DAC
tested by Accumark Labs
99.27%
View COA →
APR 14, 2026
GHK-Cu
tested by Accumark Labs
98.87%
View COA →
APR 9, 2026
GHK-Cu
tested by Accumark Labs
99.25%
View COA →
APR 8, 2026
AOD-9604
tested by Accumark Labs
98.83%
View COA →
APR 8, 2026
SELANK
tested by Accumark Labs
99.12%
View COA →
APR 7, 2026
PT-141
tested by Accumark Labs
99.84%
View COA →
APR 7, 2026
BPC-157
tested by Accumark Labs
99.42%
View COA →
APR 7, 2026
GLP-3R
tested by Accumark Labs
99.97%
View COA →
MAR 31, 2026
LL-37
tested by Accumark Labs
98.81%
View COA →
MAR 30, 2026
KPV
tested by Accumark Labs
99.62%
View COA →
MAR 30, 2026
Melanotan I (MT-1)
tested by Accumark Labs
99.48%
View COA →
MAR 30, 2026
KPV
tested by Accumark Labs
98.76%
View COA →
MAR 30, 2026
Retatrutide
tested by Accumark Labs
99.93%
View COA →
MAR 27, 2026
Tesamorelin
tested by Accumark Labs
98.34%
View COA →
MAR 26, 2026
Thymosin-Alpha 1 (A1)
tested by Accumark Labs
98.95%
View COA →
MAR 26, 2026
Melanotan II (MT-2)
tested by Accumark Labs
99.82%
View COA →
MAR 13, 2026
Retatrutide
tested by Accumark Labs
99.87%
View COA →
MAR 12, 2026
Tesamorelin
tested by Accumark Labs
99.47%
View COA →
MAR 12, 2026
Ipamorelin
tested by Accumark Labs
99.74%
View COA →
MAR 10, 2026
GHK-Cu
tested by Accumark Labs
100.00%
View COA →
MAR 6, 2026
BPC-157
tested by Accumark Labs
99.62%
View COA →
FEB 26, 2026
Retatrutide
tested by Accumark Labs
100.00%
View COA →
FEB 25, 2026
TB-500
tested by Accumark Labs
99.06%
View COA →
FEB 13, 2026
CJC-1295 without DAC
tested by Accumark Labs
99.10%
View COA →
FEB 13, 2026
Cagrilintide
tested by Accumark Labs
99.60%
View COA →
FEB 13, 2026
MOTS-C
tested by Accumark Labs
98.93%
View COA →
FEB 13, 2026
BPC-157
tested by Accumark Labs
99.05%
View COA →
FEB 12, 2026
CJC-1295 without DAC
tested by Accumark Labs
99.16%
View COA →
FEB 12, 2026
Retatrutide
tested by Accumark Labs
99.95%
View COA →
FEB 11, 2026
SEMAX
tested by Accumark Labs
99.62%
View COA →
FEB 10, 2026
Semaglutide
tested by Accumark Labs
99.57%
View COA →
FEB 10, 2026
Sermorelin
tested by Accumark Labs
98.83%
View COA →
NOV 19, 2025
Thymosin-Alpha 1 (A1)
tested by Vanguard Laboratory
99.25%
View COA →
NOV 10, 2025
GHK-Cu
tested by Vanguard Laboratory
99.50%
View COA →
NOV 10, 2025
Tesamorelin
tested by Vanguard Laboratory
98.41%
View COA →
NOV 5, 2025
SS-31 (Elamipretide)
tested by Vanguard Laboratory
99.40%
View COA →
NOV 5, 2025
CJC-1295 with DAC
tested by Vanguard Laboratory
99.49%
View COA →
NOV 5, 2025
BPC-157
tested by Vanguard Laboratory
99.80%
View COA →
NOV 5, 2025
GLP-3R
tested by Vanguard Laboratory
99.73%
View COA →
OCT 30, 2025
GHK-Cu
tested by Vanguard Laboratory
99.00%
View COA →
OCT 29, 2025
Tirzepatide
tested by Vanguard Laboratory
99.80%
View COA →
OCT 27, 2025
Ipamorelin
tested by Vanguard Laboratory
99.79%
View COA →
OCT 27, 2025
Tesamorelin
tested by Vanguard Laboratory
99.05%
View COA →
OCT 27, 2025
Retatrutide
tested by Vanguard Laboratory
99.80%
View COA →
OCT 18, 2025
TB-500
tested by Vanguard Laboratory
99.53%
View COA →
OCT 18, 2025
GHK-Cu
tested by Vanguard Laboratory
99.80%
View COA →
OCT 18, 2025
SEMAX
tested by Vanguard Laboratory
99.42%
View COA →
OCT 18, 2025
SELANK
tested by Vanguard Laboratory
99.80%
View COA →
OCT 18, 2025
MOTS-C
tested by Vanguard Laboratory
98.77%
View COA →
OCT 18, 2025
Cagrilintide
tested by Vanguard Laboratory
99.68%
View COA →
OCT 18, 2025
Retatrutide
tested by Vanguard Laboratory
99.80%
View COA →
OCT 18, 2025
Retatrutide
tested by Vanguard Laboratory
99.52%
View COA →
OCT 1, 2025
BPC-157
tested by Vanguard Laboratory
99.80%
View COA →
OCT 1, 2025
Sermorelin
tested by Vanguard Laboratory
99.80%
View COA →
OCT 1, 2025
Retatrutide
tested by Vanguard Laboratory
99.80%
View COA →
SEP 26, 2025
NAD+
tested by Vanguard Laboratory
99.68%
View COA →
SEP 9, 2025
Semaglutide
tested by Vanguard Laboratory
99.46%
View COA →
+ Submit a lab test for valorpeptides.com